Clinical Trials Update: June 2, 2009
High Cholesterol Renal Impairment Insomnia Diabetes Mellitus, Type 2 Osteoarthritis Alzheimer's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:
This study seeks people who have high cholesterol. Participants will receive all study related care and investigational medication at no cost, and may qualify for time and travel compensation.
The research site is in Chicago, Ill.
This study will compare healthy people with those who have mild, moderate and severe renal impairment.
The research site is in Indianapolis, Ind.
This study is evaluating the safety and efficacy of an investigational medication for sleep-maintenance insomnia.
The research site is in Glendale, Calif.
Diabetes Mellitus, Type 2
If you are diabetic, have been treated with pioglitazone (Actos) at a dose of 30 mg. or 45 mg. per day for at least three months, and have a HgbA1c between 7.0 percent and 10.5 percent, you may qualify for this study.
The research site is in Colorado Springs, Colo.
If you have painful osteoarthritis of the hip or knee and are taking naproxen or celecoxib, you may qualify for this study.
The research site is in Dallas, Texas.
If you or a loved one are aged 50 to 90, have mild-to-moderate Alzheimer's disease, and are being treated with Donepezil, you or the loved one may qualify for this study.
The research site is in Ocala, Fla.
Copyright 2009 ClinicalConnection.com and CenterWatch. All rights reserved.